Flavonols from Houttuynia cordata with protein glycation and aldose reductase inhibitory activity

Natural Product Sciences

Volumn 12, Issue 4, 2006, Pages 210-213

  Jang, Dae Sik ^a   Kim, Jong Min ^a   Lee, Yun Mi ^a   Yoo, Jeong Lim ^a   Kim, Young Sook ^a   Kim, Joo Hwan ^b   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Daejeon University   (South Korea)

Author keywords

AGEs; Aldose reductase; Diabetic complications; Flavonols; Houttuynia cordata; Saururaceae

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALKALOID DERIVATIVE; CEPHARADIONE; FLAVONOL DERIVATIVE; HOUTTUYNIA CORDATA EXTRACT; KAEMPFEROL 3 RHAMNOSIDE; PHENOL DERIVATIVE; PLANT EXTRACT; PROTOCATECHUIC ACID; QUERCETIN; QUERCITRIN; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HOUTTUYNIA CORDATA; MEDICINAL PLANT; NONHUMAN; PROTEIN GLYCOSYLATION;

EID: 33846529132     PISSN: 12263907     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ahmed, N., Advanced glycation endproducts-role in pathology of diabetic complications, Diabetes Res. Clin. Practice 67, 3-21 (2005).
2. Beyer-Mears, A. and Cruz, E., Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes 34, 15-21 (1985).
3. Forbes, J.M., Cooper, M.E., Oldfield, M.D., and Thomas, M.C., Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14, S254-S258 (2003).
4. Jang, D.S., Kim, J.M., Lee, Y.M., Kim, Y.S., Kim, J.-H., and Kim, J.S., Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata. Chem. Pharm. Bull. 54, 1315-1317 (2006).
5. Ji, B. and Zhao, K., Clinical application of Houttuynia cordata injection. Chin. Med. Pharm. J. 2, 14-16 (2003).
6. Kalousova, M., Zima, T., Tesar, V., Stipek, S., and Sulkova, S., Advanced glycation end products in clinical nephrology. Kidney Blood Press Res. 27, 18-28 (2004).
7. Kim, S.-K., Ryu, S.Y., No, J., Choi, S.H., and Kim, Y.S., Cytotoxic alkaloids from Houttuynia cordata. Arch. Pharm. Res. 24, 518-521 (2001).
8. Kim, H.-Y. and Oh, J.H., Screening of Korean forest plants for rat lens aldose reductase inhibition. Biosci. Biotechnol. Biochem. 63, 184-188 (1999).
9. Larkins, R.G. and M.E. Dunlop., The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35, 499-504 (1992).
10. Liu, Y.L. and Deng, Z.F., Investigation of the chemical constituents of the essential oil of Houttuynia cordata Thunb. Acta Botanica Sinica 21, 244-249 (1979).
11. Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z.H., Skolnik, E., Delaney, V., Friedman, E.A., Cerami, A., and Vlassara, H.N., Advanced glycosylation end products in patients with diabetic nephropathy. N. Eng. J. Med. 325, 836-842 (1993).
12. Matsuda, H., Morikawa, T., Toguchida, I., and Yoshikawa, M., Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chem. Pharm. Bull. 50, 788-795 (2002).
13. Matsuda, H., Wang, T., Managi, H., and Yoshikawa, M., Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 11, 5317-5323 (2003).
14. Park, J.-C., Hur, J.-M., Park, J.-W., Park, S.-J., Lee, J.-H., Sung, N.-J., Choi, M.-R., Song, S.-H., Kim, M.-S., and Lee, J.-W., The effects of Houttuynia cordata on the hepatic bromobenzene metabolizing enzyme system in rats and isolation of phenolic compounds. Kor. J. Pharmacog. 31, 228-234 (2000).
15. Pröbstle, A., Neszmely, A., Jerkovich, G, Wagner, H., and Bauer, R., Novel pyridine and 1,4-dihydropyridine alkaloids from Houttuynia cordata. Nat. Prod. Lett. 4, 235-240 (1994).
16. Rahbar, S., Yemeni, K.K., Scott, S., Gonzales, N., and Lalezari, I., Novel inhibitors of advanced glycation endproducts (Part II). Mol. Cell Biol. Res. Commun. 3, 360-366 (2000).
17. Shanghai Science and Technological Publisher, The dictionary of Chinese Drugs Vol. 1, Shougakukan, Tokyo, 1985, p. 507.
18. Shinohara, R., Mano, T., Nagasaka, A., Sawai, Y., Uchimura, K., Hayashi, R., Hayakawa, N., Nagata, M., Makino, M., Kakizawa, H., Itoh, Y., Nakai, A., and Itoh, M., Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats. Biochim. Biophys. Acta 1425, 577-586 (1998).
19. Yabe-Nishimura, C., Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50, 21-33 (1998).
20. Vinson, J.A. and Howard III, T.B., Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem. 7, 659-663 (1996).